BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Jan. 25, 2012
View Archived Issues
Promising nanoparticle-based dental treatment developed in Germany
Read More
Add-on apricoxib therapy may benefit subset of patients with pancreatic cancer
Read More
First HSP 90 inhibitor assessed in individuals with colorectal cancer
Read More
PI3K inhibitors active against gastrointestinal cancer cells
Read More
Ranbaxy Laboratories discloses novel 5-lipoxygenase inhibitors
Read More
Novel muscarinic acetylcholine M3 receptor antagonists presented
Read More
GlaxoSmithKline designs new bromodomain-containing protein inhibitors
Read More
Acura Pharmaceuticals provides Oxecta commercial update
Read More
Novel antiproliferative molecules patented at U.K. university
Read More
Belgian researchers disclose new protein kinase inhibitors
Read More
Aphios receives phase II SBIR grant to develop Alzheimer's disease therapy
Read More
Russian trial begins for Medistem's stem cell product for heart failure
Read More
Enlivex Therapeutics reports promising preliminary results in GVHD
Read More
Longitudinal data show applicability of florbetaben (18F) as a PET imaging agent in AD
Read More
NovaBay prepares to start phase IIb NVC-422 trial
Read More
Boehringer Ingelheim and Priaxon extend collaboration
Read More
Depomed starts new study of DM-1992
Read More
Almirall and BioFocus enter respiratory disease research alliance
Read More
Critical Outcome Technologies advances AML program
Read More
Johnson & Johnson highlights activities of fourth quarter 2011
Read More
Extended indication for Rebif approved in E.U.
Read More
Roche makes acquisition offer
Read More
NICE issues final guidance on Eliquis for VTE prevention in hip and knee surgery
Read More
Phase I/IIa trial launched of herbal product for Alzheimer's disease
Read More
Marina Biotech's START-FAP study advances to next stage
Read More